Christopher Beasley, PA
Physician Assistant · Omaha, NENPI 1518569961
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 97.6% of the total across 912 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 30 manufacturers, the largest accounting for just 15.4% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $3,752, 2.8 times the $1,317 reported in 2021. Among physician assistant clinicians in NE with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 912 payments — averaging $16.91 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$2K
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$2K
- Alkermes, Inc.$2K
- Teva Pharmaceuticals USA, Inc.$1K
- Vanda Pharmaceuticals Inc.$1K
- Otsuka America Pharmaceutical, Inc.$1K
- plus $5K from 24 others
What the payments were for
- Food & beverage$15,04798%
- Education$3772%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 154 | $2,377 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 98 | $1,984 |
| Alkermes, Inc. | 101 | $1,762 |
| Teva Pharmaceuticals USA, Inc. | 79 | $1,499 |
| Vanda Pharmaceuticals Inc. | 54 | $1,313 |
| Otsuka America Pharmaceutical, Inc. | 75 | $1,211 |
| Neurocrine Biosciences, Inc. | 71 | $938 |
| Johnson & Johnson | 50 | $718 |
| Lundbeck LLC | 35 | $584 |
| Sunovion Pharmaceuticals Inc. | 36 | $470 |
| Indivior Inc. | 25 | $440 |
| E.r. Squibb & Sons, L.L.C. | 29 | $428 |
| Harmony Biosciences LLC | 22 | $370 |
| Almatica Pharma LLC | 17 | $286 |
| Axsome Therapeutics, Inc. | 11 | $188 |
| Takeda Pharmaceuticals U.S.A., Inc. | 10 | $182 |
| Idorsia Pharmaceuticals US Inc | 14 | $166 |
| Noven Therapeutics, LLC | 7 | $106 |
| Bausch Health US, LLC | 4 | $88 |
| Avanir Pharmaceuticals, Inc. | 4 | $61 |
| Merck | 4 | $52 |
| Gilead | 2 | $35 |
| Eisai Inc. | 2 | $29 |
| Biohaven Pharmaceuticals, Inc. | 1 | $26 |
| Supernus Pharmaceuticals, Inc. | 1 | $24 |
| Jazz Pharmaceuticals Inc. | 2 | $23 |
| Biogen | 1 | $19 |
| Collegium Pharmaceutical, Inc. | 1 | $19 |
| Bioxcel Therapeutics, Inc. | 1 | $15 |
| Arbor Pharmaceuticals, Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$15,424 in reported general payments places this provider in the 95th percentile of 1,127 physician assistant providers in Nebraska.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| VraylarCariprazine Hcl | 159 | $234,540 |
| AustedoDeutetrabenazine | 32 | $194,534 |
| Invega TrinzaPaliperidone Palmitate | 18 | $168,424 |
| Austedo XrDeutetrabenazine | 26 | $154,874 |
| IngrezzaValbenazine Tosylate | 21 | $154,383 |
| Invega SustennaPaliperidone Palmitate | 32 | $111,163 |
| RexultiBrexpiprazole | 30 | $44,046 |
| AristadaAripiprazole Lauroxil | 17 | $41,982 |
| TrintellixVortioxetine Hydrobromide | 77 | $41,650 |
| VivitrolNaltrexone Microspheres | 22 | $38,040 |
| LybalviOlanzapine/Samidorphan Malate | 19 | $31,546 |
| CaplytaLumateperone Tosylate | 15 | $27,777 |
| BelsomraSuvorexant | 48 | $22,601 |
| Paliperidone ErPaliperidone | 88 | $18,728 |
| Chlorpromazine Hcl | 108 | $17,413 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Teva Pharmaceuticals USA, Inc.Austedo, Austedo Xr | $1,499 | $349,40858 claims |
| Johnson & JohnsonInvega Trinza, Invega Sustenna | $718 | $279,58850 claims |
| AbbVieVraylar | $2,377 | $234,540159 claims |
| Neurocrine Biosciences, Inc.Ingrezza | $938 | $154,38321 claims |
| Alkermes, Inc.Aristada, Vivitrol, Lybalvi | $1,762 | $111,56858 claims |
| Takeda Pharmaceuticals U.S.A., Inc.Trintellix, Vyvanse | $182 | $47,01892 claims |
| Otsuka America Pharmaceutical, Inc.Rexulti | $1,211 | $44,04630 claims |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)Caplyta | $1,984 | $27,77715 claims |
| MerckBelsomra | $52 | $22,60148 claims |
| Idorsia Pharmaceuticals US IncQuviviq | $166 | $11,48423 claims |
| Indivior Inc.Suboxone | $440 | $7,31417 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 1,127 physician assistant providers in Nebraska.
Other physician assistant in Omaha
- Kimberly GatesOmaha$109K
- Kandice DoleshOmaha$106K
- Kathryn KestiOmaha$34K
- Sarah GretemanOmaha$24K
- Corrine GiggeeOmaha$12K
- Austin DuerksenOmaha$12K
- Erin HoffmanOmaha$12K
- Sara MasonOmaha$12K
- Sally CampbellOmaha$9K
- Angela KlineOmaha$9K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.